Form 4 holding
10%+ Owner
Verve Therapeutics, Inc.
- Security class
- Common Stock
- Shares / value
- 443,265
- Estimated value
- $4,432,650
- Report date
- 21 Jun 2021
- Price
- $10.00
- Ownership
- Indirect
Logos Global Management LP
Insider Reports History
- Reporting-owner location
- San Francisco, CA
- Latest reporting-owner signature
-
/s/Arsani William, Managing Partner
Source: Latest parsed Forms 3/4/5 signature
- Transaction source note
- Rows are grouped by transaction date from the original SEC filing. Open the aggregated insider activity page to review issuer-level activity across dates.
Identity
Names, identifiers, and filing context for this profile.
1 identity field
SEC source record
Original filing metadata and source links for verification.
1 source field
Source evidence
Original filing metadata and source links for verification.
1 source field
Reported holdings for Logos Global Management LP
Form 4 holding
10%+ Owner
Verve Therapeutics, Inc.
- Security class
- Common Stock
- Shares / value
- 370,000
- Estimated value
- $3,700,000
- Report date
- 21 Jun 2021
- Price
- $10.00
- Ownership
- Direct
Form 4 holding
10%+ Owner
Verve Therapeutics, Inc.
- Security class
- Series B Preferred Stock
- Shares / value
- 0
- Estimated value
- Report date
- 21 Jun 2021
- Price
- Ownership
- Indirect
- Underlying class
- Common Stock
- Underlying amount
Insider Reports Filed by Logos Global Management LP
4
VERV
Verve Therapeutics, Inc.
- Report period
- 21 Jun 2021
- Transactions
- 3
- Transaction value
- +$7,030,000
- Accepted by SEC
- 22 Jun 2021, 17:21
- Role
- 10%+ Owner
- Next action
- Open filing details
3
VERV
Verve Therapeutics, Inc.
- Report period
- 16 Jun 2021
- Transactions
- 0
- Transaction value
- $0
- Accepted by SEC
- 16 Jun 2021, 19:20
- Role
- 10%+ Owner
- Next action
- Open filing details